David G J Cucchi (David GJ Cucchi, David Gj Cucchi, D G J Cucchi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Topics

Systematic Review

Gene Expression

Acute Myeloid Leukemia

Top Venues

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

David G J Cucchi, Annebel Govers, Frank H Janse, Bas M van Dalen
Acute perimyocarditis associated with Bartonella henselae infection. BMJ case reports 16 (11) (2023)
Tobias B Polak, David G J Cucchi, Jasmin Schelhaas, Syed S Ahmed, Naima Khoshnaw, Joost van Rosmalen, Carin A Uyl-de Groot
Results from Expanded Access Programs: A Review of Academic Literature. Drugs (2023)
David G J Cucchi, Sonja Zweegman
Equality: trial and error? Blood 142 (3) (2023)
Tobias B Polak, David G J Cucchi, Jasmin Schelhaas, Syed S Ahmed, Naima Khoshnaw, Joost van Rosmalen, Carin A Uyl-de Groot
Results from Expanded Access Programs: A Review of Academic Literature. Drugs (2023)
Maarten R Seefat, David G J Cucchi, K Groen, M L Donker, K G van der Hem, M Westerman, A M Gerrits, A Beeker, Niels W C J van de Donk, Hedwig M Blommestein, Sonja Zweegman
Treatment sequences and drug costs from diagnosis to death in multiple myeloma. European journal of haematology (2023)
David G J Cucchi, Tobias B Polak, Gert J Ossenkoppele, Jacob M Rowe, Elihu H Estey
The predictive value of a positive phase 2 ASH abstract for peer-reviewed publication and progression to phase 3. Blood 139 (12) (2022)
Tobias B Polak, David G J Cucchi, Jonathan J Darrow, Matthijs M Versteegh
Incremental benefits of novel pharmaceuticals in the UK: a cross-sectional analysis of NICE technology appraisals from 2010 to 2020. BMJ open 12 (4) (2022)
Tobias B Polak, David G J Cucchi, Joost van Rosmalen, Carin A Uyl-de Groot
Real-world data from expanded access programmes in health technology assessments: a review of NICE technology appraisals. BMJ open 12 (1) (2022)
Maarten R Seefat, David G J Cucchi, Stijn Dirven, Kaz Groen, Sonja Zweegman, Hedwig M Blommestein
A Systematic Review of Cost-Effectiveness Analyses of Novel Agents in the Treatment of Multiple Myeloma. Cancers 13 (22) (2021)
David G J Cucchi, Tobias B Polak, Gert J Ossenkoppele, Carin A Uyl-De Groot, Jacqueline Cloos, Sonja Zweegman, Jeroen J W M Janssen
Two decades of targeted therapies in acute myeloid leukemia. Leukemia 35 (3) (2021)
Carolien Duetz, David G J Cucchi, Tobias B Polak, Jeroen J W M Janssen, Gert J Ossenkoppele, Elihu H Estey, Arjan A van de Loosdrecht
The wider perspective: twenty years of clinical trials in myelodysplastic syndromes. British journal of haematology (2021)
David G J Cucchi, Christian M Vonk, Melissa Rijken, François G Kavelaars, Pauline A Merle, Elvira Verhoef, Bianca Venniker-Punt, Zinia J Kwidama, Patrycja L Gradowska, Bob Löwenberg, Jeroen J W M Janssen, Jacqueline Cloos, Peter J M Valk
DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemia. Blood advances 5 (21) (2021)
David G J Cucchi, Costa Bachas, Marry M van den Heuvel-Eibrink, Susan T C J M Arentsen-Peters, Zinia J Kwidama, Gerrit J Schuurhuis, Yehuda G Assaraf, Valerie de Haas, Gertjan J L Kaspers, Jacqueline Cloos
Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid Leukemia. Cancers 12 (5) (2020)
David G J Cucchi, Costa Bachas, Kim Klein, Sander Huttenhuis, Christian M Zwaan, Gert J Ossenkoppele, Jeroen M W M Janssen, Gertjan L Kaspers, Jacqueline Cloos
TP53 mutations and relevance of expression of TP53 pathway genes in paediatric acute myeloid leukaemia. British journal of haematology 188 (5) (2019)